Resveratrol for cancer therapy: Challenges and future perspectives

Resveratrol (3,4’,5-trihydroxy-trans-stilbene) has been expected to ameliorate cancer and foster breakthroughs in cancer therapy. Despite thousands of preclinical studies on the anticancer activity of resveratrol, little progress has been made in translational research and clinical trials. Most stud...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cancer letters Ročník 515; s. 63 - 72
Hlavní autoři:	Ren, Boxu, Kwah, Marabeth Xin-Yi, Liu, Cuiliu, Ma, Zhaowu, Shanmugam, Muthu K., Ding, Lingwen, Xiang, Xiaoqiang, Ho, Paul Chi-Lui, Wang, Lingzhi, Ong, Pei Shi, Goh, Boon Cher
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Ireland Elsevier B.V 01.09.2021 Elsevier Limited
Témata:	Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Antitumor activity Antitumor agents Bioavailability Biomarkers Cancer Cancer therapies Cancer treatment Chemotherapy Clinical trials Colorectal cancer Cytotoxicity Functional foods & nutraceuticals Humans Insulin Insulin-like growth factors Multiple myeloma Neoplasms - drug therapy Pharmacodynamics Pharmacokinetics Plasma Proteins Resveratrol Resveratrol - pharmacology Resveratrol - therapeutic use Signal transduction Signal Transduction - drug effects Skin Toxicity trans-Stilbene Tumor necrosis factor-TNF Tumorigenesis Cmax PGE2 Pharmacodynamics AST Cancer treatment Toxicity VEGF ALT IGF-1 Vd RASSF-1a MCP1 IGFBP-3 MPX TNF-α Resveratrol IC50 Tmax AMPK Pharmacokinetics Wnt
ISSN:	0304-3835, 1872-7980, 1872-7980
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!